Boehringer Ingelheim USA Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

Recruiting
Conditions
Interventions
First Posted Date
2023-01-04
Last Posted Date
2024-11-21
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
40
Registration Number
NCT05670821
Locations
🇯🇵

Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan

A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device

First Posted Date
2023-01-04
Last Posted Date
2024-04-10
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
53
Registration Number
NCT05670587
Locations
🇧🇪

Kortrijk - HOSP AZ Groeninge Kennedylaan, Kortrijk, Belgium

🇺🇸

Critical Care, Pulmonary and Sleep Associates, Lakewood, Colorado, United States

🇺🇸

Southeastern Research Center, Winston-Salem, North Carolina, United States

and more 10 locations

A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-12-22
Last Posted Date
2024-08-09
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
28
Registration Number
NCT05661344
Locations
🇩🇪

CRS Clinical Research Services Kiel GmbH, Kiel, Germany

A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-12-20
Last Posted Date
2024-04-03
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
64
Registration Number
NCT05658107
Locations
🇧🇪

SGS Life Science Services - Clinical Research, Edegem, Belgium

A Study in Healthy Chinese People to Test How Different Doses of BI 1015550 Are Taken up in the Body

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-12-01
Last Posted Date
2023-08-14
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
24
Registration Number
NCT05633862
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the Body

First Posted Date
2022-11-14
Last Posted Date
2024-11-19
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
13
Registration Number
NCT05613036
Locations
🇭🇺

PRA Hungary Ltd., Budapest, Hungary

A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-11-14
Last Posted Date
2023-10-19
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
19
Registration Number
NCT05613777
Locations
🇩🇪

CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany

A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2022-09-29
Last Posted Date
2024-12-03
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
188
Registration Number
NCT05559580
Locations
🇺🇸

Augusta University, Augusta, Georgia, United States

🇺🇸

Tufts Medical Center, Boston, Massachusetts, United States

🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

and more 122 locations

A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Midazolam in the Blood

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-09-22
Last Posted Date
2022-12-21
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
15
Registration Number
NCT05550636
Locations
🇩🇪

CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany

© Copyright 2024. All Rights Reserved by MedPath